biotechnology

Kane Biotech announces update on private placement

Kane Biotech announces extension of private placement

Not for distribution to US news services or broadcast in the United States WINNIPEG, Manitoba, April 29, 2022 (GLOBE NEWSWIRE) – Kane Biotech Inc. (TSX-V: KNE) (the “Company” or “Kane Biotech”) today announced that it has extended the completion of its previously announced non-offering. private placement brokerage (the “Offer”) within 30 days until May 29, …

Kane Biotech announces extension of private placement Read More »

The legislator has addressed the problems of agriculture from biodiesel to biotechnology |  State

The legislator has addressed the problems of agriculture from biodiesel to biotechnology | State

With primary elections in sight, state lawmakers concluded a legislative session in the spring despite missing the deadline for the April 8 session by several hours. As for agriculture, notable achievements include the extension of the tax incentive on biodiesel sales as part of a larger tax package covered by a nearly 900-page invoice that …

The legislator has addressed the problems of agriculture from biodiesel to biotechnology | State Read More »

"The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020": why contrarians say the sector is a purchase

“The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020”: why contrarians say the sector is a purchase

If you want to know how much investors hate the biotech sector right now, consider this simple statistic: More than 25% of small biotech companies have less stock market capitalizations than they have in cash. “The market is saying that a quarter of these companies are literally worth nothing,” says Jefferies biotech analyst Michael Yee, …

“The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020”: why contrarians say the sector is a purchase Read More »

"The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020": why contrarians say the sector is a purchase

“The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020”: why contrarians say the sector is a purchase

If you want to know how much investors hate the biotech sector right now, consider this simple statistic: More than 25% of small biotech companies have less stock market capitalizations than they have in cash. “The market is saying that a quarter of these companies are literally worth nothing,” says Jefferies biotech analyst Michael Yee, …

“The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020”: why contrarians say the sector is a purchase Read More »

"The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020": why contrarians say the sector is a purchase

“The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020”: why contrarians say the sector is a purchase

If you want to know how much investors hate the biotech industry right now, consider this simple statistic: More than 25% of small biotech companies have lower market capitalizations than they have in cash. “The market is saying that a quarter of these companies are literally worth nothing,” says Jefferies biotech analyst Michael Yee, who …

“The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020”: why contrarians say the sector is a purchase Read More »

OK'd Biotechnology Campus in Millbrae |  Local news

OK’d Biotechnology Campus in Millbrae | Local news

A planned cluster of biotech campuses in Millbrae near the train station is one step closer to taking shape, with approval granted this week for a six-story campus at 210 Adrian Road. The 263,000-square-foot building is designed for a 2-acre lot currently occupied by a self-contained storage facility adjacent to the train tracks and Millbrae …

OK’d Biotechnology Campus in Millbrae | Local news Read More »

It's another bad week for biotech stocks.  Relief could come next month.

It’s another bad week for biotech stocks. Relief could come next month.

Text size About 80 biotechnologies in Russell 2000 have market capitalizations below last year’s inclusion limit. Time to dream The biotech acquisitions were supposed to revive the sector, but despite the biggest deal reached this year, this was yet another bad week, very bad for equities. The end may come soon, painfully but positively, according …

It’s another bad week for biotech stocks. Relief could come next month. Read More »

Cathie Wood Watch: Ark buys international e-commerce, biotech stocks

Cathie Wood Watch: Ark buys international e-commerce, biotech stocks

Renowned investor Cathie Wood, chief executive of Ark Investment Management, bought stock in a biotech and technology company focused on enabling international e-commerce. It also sold four companies. All valuations below are as of Tuesday’s close. Ark Fintech Innovation ETF (ARKF) – Get the ARK fintech innovation ETF report purchased 96,707 shares of Global-E Online …

Cathie Wood Watch: Ark buys international e-commerce, biotech stocks Read More »

OSI Systems receives $ 4 million in orders for electronic components

PDS Biotech will participate in the upcoming investor conferences

FLORHAM PARK, NJ, May 17, 2022 (GLOBE NEWSWIRE) – PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and infectious disease vaccines based on the company’s patented Versamune system® and Infectimune â„¢ T-Cell Activation Technologies, announced today that its management will attend the HC Wainwright Global …

PDS Biotech will participate in the upcoming investor conferences Read More »

Biotech beauty must be a priority for innovation in cosmetics, says the founder of Mibelle Biochemistry

Biotech beauty must be a priority for innovation in cosmetics, says the founder of Mibelle Biochemistry

The ongoing climate crisis and far-reaching climate neutrality goals set by the European Union (EU) have brought sustainability and “going green” into the brightest spotlight in recent times. And as the world continued to navigate new ways of doing business, technology and innovation were cited as keys to creating change. And that was also true …

Biotech beauty must be a priority for innovation in cosmetics, says the founder of Mibelle Biochemistry Read More »